Literature DB >> 29142124

Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.

Ellen White1, Fan Wu1, Elena Chertova2, Julian Bess2, James D Roser2, Jeffrey D Lifson2, Vanessa M Hirsch3.   

Abstract

An incomplete understanding of native human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) envelope glycoproteins (Envs) impedes the development of structural models of Env and vaccine design. This shortcoming is due in part to the low number of Env trimers on virus particles. For SIV, this low expression level can be counteracted by truncating the cytoplasmic tail (CT) of Env. CT truncation has been shown to increase Env incorporation into the virion and is commonly used in vaccine and imaging studies, but its effects on viral antigenicity have not been fully elucidated. To study the effects of a CT truncation of Env in viruses in similar genetic contexts, we introduced stop codons into the CT of a SIVsmE660 molecular clone and two neutralizing antibody (NAb) escape variants. These viruses shared 98% sequence identity in Env but were characterized as either tier 1 (sensitive to neutralization), tier 2 (moderately resistant to neutralization), or tier 3 (resistant to neutralization). However, the introduction of premature stop codons in Env at position Q741/Q742 converted all three transfection-derived viruses to a tier 3-like phenotype, and these viruses were uniformly resistant to neutralization by sera from infected macaques and monoclonal antibodies (MAbs). These changes in neutralization sensitivity were not accompanied by an increase in either the virion Env content of infection-derived viruses or the infectivity of transfection-derived viruses in human cells, suggesting that CT mutations may result in global changes to the Env conformation. Our results demonstrate that some CT truncations can affect viral antigenicity and, as such, may not be suitable surrogate models of native HIV/SIV Env.IMPORTANCE Modifications to the SIV envelope protein (Env) are commonly used in structural and vaccine studies to stabilize and increase the expression of Env, often without consideration of effects on antigenicity. One such widespread modification is the truncation of the Env C-terminal tail. Here, we studied the effects of a particular cytoplasmic tail truncation in three SIVsm strains that have highly similar Env sequences but exhibit different sensitivities to neutralizing antibodies. After truncation of the Env CT, these viruses were all very resistant to neutralization by sera from infected macaques and monoclonal antibodies. The viruses with a truncated Env CT also did not exhibit the desired and typical increase in Env expression. These results underscore the importance of carefully evaluating the use of truncated Env as a model in HIV/SIV vaccine and imaging studies and of the continued need to find better models of native Env that contain fewer modifications.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  macaques; neutralizing antibodies; simian immunodeficiency virus; viral envelope

Mesh:

Substances:

Year:  2018        PMID: 29142124      PMCID: PMC5774881          DOI: 10.1128/JVI.01688-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.

Authors:  Guiqing Hu; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.

Authors:  A N Vzorov; R W Compans
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.

Authors:  Eloísa Yuste; Welkin Johnson; George N Pavlakis; Ronald C Desrosiers
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein.

Authors:  Jia Chen; James M Kovacs; Hanqin Peng; Sophia Rits-Volloch; Jianming Lu; Donghyun Park; Elise Zablowsky; Michael S Seaman; Bing Chen
Journal:  Science       Date:  2015-06-25       Impact factor: 47.728

Review 5.  The cytoplasmic tail of retroviral envelope glycoproteins.

Authors:  Philip R Tedbury; Eric O Freed
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

6.  Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells.

Authors:  P B Johnston; J W Dubay; E Hunter
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.

Authors:  K Zingler; D R Littman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

9.  Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail.

Authors:  Takeo Kuwata; Takaki Kaori; Ikumi Enomoto; Kazuhisa Yoshimura; Shuzo Matsushita
Journal:  Front Microbiol       Date:  2013-05-14       Impact factor: 5.640

10.  Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry.

Authors:  Rachid Sougrat; Alberto Bartesaghi; Jeffrey D Lifson; Adam E Bennett; Julian W Bess; Daniel J Zabransky; Sriram Subramaniam
Journal:  PLoS Pathog       Date:  2007-05-04       Impact factor: 6.823

View more
  6 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges.

Authors:  Matthew R Gardner; Christoph H Fellinger; Lisa M Kattenhorn; Meredith E Davis-Gardner; Jesse A Weber; Barnett Alfant; Amber S Zhou; Neha R Prasad; Hema R Kondur; Wendy A Newton; Kimberly L Weisgrau; Eva G Rakasz; Jeffrey D Lifson; Guangping Gao; Nancy Schultz-Darken; Michael Farzan
Journal:  Sci Transl Med       Date:  2019-07-24       Impact factor: 17.956

3.  BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.

Authors:  Yanhui Cai; Mohamed Abdel-Mohsen; Costin Tomescu; Fengtian Xue; Guoxin Wu; Bonnie J Howell; Yong Ai; Jie Sun; Livio Azzoni; Carole Le Coz; Neil Romberg; Luis J Montaner
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

4.  HIV envelope tail truncation confers resistance to SERINC5 restriction.

Authors:  Tafhima Haider; Xenia Snetkov; Clare Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 12.779

5.  Meeting Review: 2018 International Workshop on Structure and Function of the Lentiviral gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Eric O Freed
Journal:  Viruses       Date:  2018-11-07       Impact factor: 5.048

6.  Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.

Authors:  Xue-Feng Wang; Yu-Hong Wang; Bowen Bai; Mengmeng Zhang; Jie Chen; Xiangmin Zhang; Min Gao; Xiaojun Wang
Journal:  J Virol       Date:  2021-09-08       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.